References
- Sulzberger M B, Witten V H, Yaffe S N. Cortisone acetate administered orally in dermatologic therapy. Arch Dermatol Syph 1951; 64: 573–9
- Brunsting L A, Reed W B, Bair H. Occurrence of cataracts and keratoconus in atopic dermatitis. Arch Dermatol 1955; 72: 237–243
- Sulzberger M B, Witten V H. Preliminary and short reports. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 1952; 19: 101–2
- Tauber U. Dermatocorticosteroids: structure, activity, pharmacokinetics. Eur J Dermatol 1994; 4: 419–29
- Bodor N. The application of soft drug approaches to the design of safer corticosteroids. Topical corticosteroid therapy, E Christophers, A M Kligman, E Schopf, et al. Raven Press, New York 1988; 13–25
- Degreef H, Dooms-Goossens A. The new corticosteroids: are they effective and safe. Dermatologic Clin 1993; 11: 155–60
- Korting H C, Kerscher M J, Schafer-Korting M. Topical glucocorticoids with improved benefit-risk ratio: do they exist?. J Am Acad Dermatol 1992; 27: 87–92
- Harding S M, Sohail S, Buss M J. Percutaneous absorption of clobetesol propionate from novel ointment and cream formulations. Clin Exp Dermatol 1985; 10: 13–21
- Bronough R L, Maibach H I. In vitro percutaneous absorption: principles, fundamentals and applications. CRC Press, Boca Raton 1991
- Arbiser J L, Grossman K, Kaye E, Arndt K A. Use of short course class I topical glucocorticoid under occlusion for rapid control of erythrodermic psoriasis. Arch Dermatol 1994; 130: 704–6
- Vickers C FN. Existence of a reservoir in the stratum corneum. Arch Dermatol 1963; 88: 20–25
- McKenzie A W, Stoughton R B. Method comparing percutaneous absorption of steroids. Arch Dermatol 1962; 88: 608–10
- Cornell R C, Stoughton R B. Correlation of vasoconstrictor assay and clinical activity in psoriasis. Arch Dermatol 1985; 121: 63–7
- Lavker R M, Schecuter N M, Lazarus S M. Effects of topical steroids on human dermis. Br J Dermatol 1986; 115(Suppl 31)101–7
- Ashworth J, Booker J, Breathnach S M. Effect of corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol 1988; 118: 457–70
- English J SC, Bunker C B, Ruthuen K, et al. A double blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatosis. Clin Exp Dermatol 1989; 14: 32–4
- Greaves M W, Hay R J. Topical corticosteroids. J Roy Coll Physicians Lond 1987; 21: 32–4
- Turpeinen M, Salo O P, Leisti S. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986; 115: 475–84
- Patel L, Clayton P E, Addison G M, et al. Adrenal function following topical steroid treatment in children with atopic dermatitis. Br J Dermatol 1995; 132: 950–5
- Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. BMJ 1969; 1: 671–3
- Dooms-Goossens A, Morren M. Results of routine patch testing with corticosteroid series in 2073patients. Contact Dermatitis 1992; 26: 182–91
- Du Vivier A, Stoughton R B. Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol 1975; 111: 581–3
- Gniadecki R, Gniadecka M, Serup J. Inhibition of glucocorticoid-induced epidermal atrophy with KH 1060— a potent 20-epi analogue of 1,25-dihydroxy vitamin D3. Br J Pharmacol 1994; 113: 439–44